Mycobacterium tuberculosis is a hard-to-eradicate intracellular pathogen that infects one-third of the global population. It can live within macrophages owning to its ability to arrest phagolysosome biogenesis. Autophagy has recently been identified as an effective way to control the intracellular mycobacteria by enhancing phagosome maturation. In the present study, we demonstrate a novel role of miR-155 in regulating the autophagy-mediated anti-mycobacterial response. Both in vivo and in vitro studies showed that miR-155 expression was significantly enhanced after mycobacterial infection. Forced expression of miR-155 accelerated the autophagic response in macrophages, thus promoting the maturation of mycobacterial phagosomes and decreasing the survival rate of intracellular mycobacteria, while transfection with miR-155 inhibitor increased mycobacterial survival. However, macrophage-mediated mycobacterial phagocytosis was not affected after miR-155 overexpression or inhibition. Furthermore, blocking autophagy with specific inhibitor 3-methyladenine or silencing of autophagy related gene 7 (Atg7) reduced the ability of miR-155 to promote autophagy and mycobacterial elimination. More importantly, our study demonstrated that miR-155 bound to the 3′-untranslated region of Ras homologue enriched in brain (Rheb), a negative regulator of autophagy, accelerated the process of autophagy and sequential killing of intracellular mycobacteria by suppressing Rheb expression. Our results reveal a novel role of miR-155 in regulating autophagy-mediated mycobacterial elimination by targeting Rheb, and provide potential targets for clinical treatment.
References
[1]
Russell DG, Barry CE (2010) Tuberculosis: what we don't know can, and does, hurt us. Science 328: 852–856. doi: 10.1126/science.1184784
[2]
Korbel DS, Schneider BE, Schaible UE (2008) Innate immunity in tuberculosis: myths and truth. Microbes Infect 10: 995–1004. doi: 10.1016/j.micinf.2008.07.039
[3]
Quesniaux V, Fremond C, Jacobs M, Parida S, Nicolle D, et al. (2004) Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect 6: 946–959. doi: 10.1016/j.micinf.2004.04.016
[4]
Hernandez-Pando R, Orozco H, Aguilar D (2009) Factors that deregulate the protective immune response in tuberculosis. Arch Immunol Ther Exp (Warsz) 57: 355–367. doi: 10.1007/s00005-009-0042-9
[5]
Bhatt K, Salgame P (2007) Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol 27: 347–362. doi: 10.1007/s10875-007-9084-0
[6]
Baena A, Porcelli SA (2009) Evasion and subversion of antigen presentation by Mycobacterium tuberculosis. Tissue Antigens 74: 189–204. doi: 10.1111/j.1399-0039.2009.01301.x
[7]
Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, et al. (2004) Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119: 753–766. doi: 10.1016/j.cell.2004.11.038
[8]
Deretic V, Singh S, Master S, Harris J, Roberts E, et al. (2006) Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cell Microbiol 8: 719–727. doi: 10.1111/j.1462-5822.2006.00705.x
[9]
Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132: 27–42. doi: 10.1016/j.cell.2007.12.018
[10]
Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451: 1069–1075. doi: 10.1038/nature06639
[11]
Levine B, Klionsky DJ (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463–477. doi: 10.1016/s1534-5807(04)00099-1
[12]
Delgado M, Singh S, De Haro S, Master S, Ponpuak M, et al. (2009) Autophagy and pattern recognition receptors in innate immunity. Immunol Rev 227: 189–202. doi: 10.1111/j.1600-065x.2008.00725.x
[13]
Ogawa M, Yoshimori T, Suzuki T, Sagara H, Mizushima N, et al. (2005) Escape of intracellular Shigella from autophagy. Science 307: 727–731. doi: 10.1126/science.1106036
[14]
Birmingham CL, Smith AC, Bakowski MA, Yoshimori T, Brumell JH (2006) Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J Biol Chem 281: 11374–11383. doi: 10.1074/jbc.m509157200
[15]
Rich KA, Burkett C, Webster P (2003) Cytoplasmic bacteria can be targets for autophagy. Cell Microbiol 5: 455–468. doi: 10.1046/j.1462-5822.2003.00292.x
[16]
Levine B, Mizushima N, Virgin HW (2011) Autophagy in immunity and inflammation. Nature 469: 323–335. doi: 10.1038/nature09782
[17]
Sanjuan MA, Milasta S, Green DR (2009) Toll-like receptor signaling in the lysosomal pathways. Immunol Rev 227: 203–220. doi: 10.1111/j.1600-065x.2008.00732.x
[18]
Deretic V (2010) Autophagy in infection. Curr Opin Cell Biol 22: 252–262. doi: 10.1016/j.ceb.2009.12.009
[19]
Levine B, Yuan J (2005) Autophagy in cell death: an innocent convict? J Clin Invest 115: 2679–2688. doi: 10.1172/jci26390
[20]
Fu LL, Wen X, Bao JK, Liu B (2012) MicroRNA-modulated autophagic signaling networks in cancer. Int J Biochem Cell Biol 44: 733–736. doi: 10.1016/j.biocel.2012.02.004
[21]
Taganov KD, Boldin MP, Baltimore D (2007) MicroRNAs and immunity: tiny players in a big field. Immunity 26: 133–137. doi: 10.1016/j.immuni.2007.02.005
[22]
Rajaram MV, Ni B, Morris JD, Brooks MN, Carlson TK, et al. (2011) Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proc Natl Acad Sci U S A 108: 17408–17413. doi: 10.1073/pnas.1112660108
[23]
Liu Y, Wang X, Jiang J, Cao Z, Yang B, et al. (2011) Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis. Mol Immunol 48: 1084–1090. doi: 10.1016/j.molimm.2011.02.001
[24]
Ma F, Xu S, Liu X, Zhang Q, Xu X, et al. (2011) The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol 12: 861–869. doi: 10.1038/ni.2073
[25]
Top EM, Wilson DB (2011) Special issue of Current Opinion in Microbiology, focused on ‘Ecology and Industrial Microbiology’. Curr Opin Microbiol 14: 227–228. doi: 10.1016/j.mib.2011.04.008
[26]
O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104: 1604–1609. doi: 10.1073/pnas.0610731104
[27]
Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, et al. (2009) MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci U S A 106: 2735–2740. doi: 10.1073/pnas.0811073106
[28]
Eis PS, Tam W, Sun L, Chadburn A, Li Z, et al. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102: 3627–3632. doi: 10.1073/pnas.0500613102
[29]
Haasch D, Chen YW, Reilly RM, Chiou XG, Koterski S, et al. (2002) T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell Immunol 217: 78–86. doi: 10.1016/s0008-8749(02)00506-3
[30]
Xiao B, Liu Z, Li BS, Tang B, Li W, et al. (2009) Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis 200: 916–925. doi: 10.1086/605443
[31]
Ghorpade DS, Leyland R, Kurowska-Stolarska M, Patil SA, Balaji KN (2012) MicroRNA-155 is required for M. bovis BCG mediated apoptosis of macrophages. Mol Cell Biol 32: 2239–2253. doi: 10.1128/mcb.06597-11
[32]
Wu J, Lu C, Diao N, Zhang S, Wang S, et al. (2012) Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study. Hum Immunol 73: 31–37. doi: 10.1016/j.humimm.2011.10.003
[33]
Faraoni I, Antonetti FR, Cardone J, Bonmassar E (2009) miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792: 497–505. doi: 10.1016/j.bbadis.2009.02.013
[34]
Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, et al. (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316: 608–611. doi: 10.1126/science.1139253
[35]
O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, et al. (2010) MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33: 607–619. doi: 10.1016/j.immuni.2010.09.009
[36]
Suzuki HI, Arase M, Matsuyama H, Choi YL, Ueno T, et al. (2011) MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation. Mol Cell 44: 424–436. doi: 10.1016/j.molcel.2011.09.012
[37]
Arranz A, Doxaki C, Vergadi E, Martinez de la Torre Y, Vaporidi K, et al. (2012) Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A 109: 9517–9522. doi: 10.1073/pnas.1119038109
[38]
Liu PT, Modlin RL (2008) Human macrophage host defense against Mycobacterium tuberculosis. Curr Opin Immunol 20: 371–376. doi: 10.1016/j.coi.2008.05.014
[39]
Bermudez LE, Young LS (1988) Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 140: 3006–3013.
[40]
Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, et al. (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2: 561–572. doi: 10.1016/1074-7613(95)90001-2
[41]
Fratazzi C, Arbeit RD, Carini C, Remold HG (1997) Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J Immunol 158: 4320–4327.
[42]
Lee J, Remold HG, Ieong MH, Kornfeld H (2006) Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J Immunol 176: 4267–4274. doi: 10.4049/jimmunol.176.7.4267
[43]
Levine B, Deretic V (2007) Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 7: 767–777. doi: 10.1038/nri2161
[44]
Herbst S, Schaible UE, Schneider BE (2011) Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PLoS One 6: e19105. doi: 10.1371/journal.pone.0019105
[45]
Jagannath C, Lindsey DR, Dhandayuthapani S, Xu Y, Hunter RL Jr, et al. (2009) Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med 15: 267–276. doi: 10.1038/nm.1928
[46]
Kim JJ, Lee HM, Shin DM, Kim W, Yuk JM, et al. (2012) Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action. Cell Host Microbe 11: 457–468. doi: 10.1016/j.chom.2012.03.008
[47]
Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, et al. (2001) Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291: 1544–1547. doi: 10.1126/science.291.5508.1544
[48]
Vila-del Sol V, Diaz-Munoz MD, Fresno M (2007) Requirement of tumor necrosis factor alpha and nuclear factor-kappaB in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages. J Leukoc Biol 81: 272–283. doi: 10.1189/jlb.0905529
[49]
Dharmaraja AT, Alvala M, Sriram D, Yogeeswari P, Chakrapani H (2012) Design, synthesis and evaluation of small molecule reactive oxygen species generators as selective Mycobacterium tuberculosis inhibitors. Chem Commun (Camb) 48: 10325–10327. doi: 10.1039/c2cc35343a
[50]
Wang P, Hou J, Lin L, Wang C, Liu X, et al. (2010) Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol 185: 6226–6233. doi: 10.4049/jimmunol.1000491
[51]
Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, et al. (2007) microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27: 847–859. doi: 10.1016/j.immuni.2007.10.009
[52]
O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, et al. (2008) Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 205: 585–594. doi: 10.1084/jem.20072108
[53]
O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D (2009) Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A 106: 7113–7118. doi: 10.1073/pnas.0902636106
[54]
Tang B, Xiao B, Liu Z, Li N, Zhu ED, et al. (2010) Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation. FEBS Lett 584: 1481–1486. doi: 10.1016/j.febslet.2010.02.063
[55]
Huang X, Shen Y, Liu M, Bi C, Jiang C, et al. (2012) Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma. Am J Pathol 181: 26–33. doi: 10.1016/j.ajpath.2012.03.013
[56]
Sun YM, Lin KY, Chen YQ (2013) Diverse functions of miR-125 family in different cell contexts. J Hematol Oncol 6: 6. doi: 10.1186/1756-8722-6-6
[57]
Zhao A, Zeng Q, Xie X, Zhou J, Yue W, et al. (2012) MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression. J Genet Genomics 39: 29–35. doi: 10.1016/j.jgg.2011.12.003
[58]
Zeng CW, Zhang XJ, Lin KY, Ye H, Feng SY, et al. (2012) Camptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathways. Mol Pharmacol 81: 578–586. doi: 10.1124/mol.111.076794
[59]
Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, et al. (2003) Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11: 1457–1466. doi: 10.1016/s1097-2765(03)00220-x
[60]
Bose SK, Shrivastava S, Meyer K, Ray RB, Ray R (2012) Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance. J Virol 86: 6315–6322. doi: 10.1128/jvi.00050-12
[61]
Seo G, Kim SK, Byun YJ, Oh E, Jeong SW, et al. (2011) Hydrogen peroxide induces Beclin 1-independent autophagic cell death by suppressing the mTOR pathway via promoting the ubiquitination and degradation of Rheb in GSH-depleted RAW 264.7 cells. Free Radic Res 45: 389–399. doi: 10.3109/10715762.2010.535530
[62]
Tattoli I, Sorbara MT, Vuckovic D, Ling A, Soares F, et al. (2012) Amino acid starvation induced by invasive bacterial pathogens triggers an innate host defense program. Cell Host Microbe 11: 563–575. doi: 10.1016/j.chom.2012.04.012
[63]
Liao XH, Majithia A, Huang X, Kimmel AR (2008) Growth control via TOR kinase signaling, an intracellular sensor of amino acid and energy availability, with crosstalk potential to proline metabolism. Amino Acids 35: 761–770. doi: 10.1007/s00726-008-0100-3
[64]
Tanida I, Yamaji T, Ueno T, Ishiura S, Kominami E, et al. (2008) Consideration about negative controls for LC3 and expression vectors for four colored fluorescent protein-LC3 negative controls. Autophagy 4: 131–134.
[65]
Mariencheck WI, Savov J, Dong Q, Tino MJ, Wright JR (1999) Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa. Am J Physiol 277: L777–786.
